Navigation Links
Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis
Date:9/3/2008

Third Clinical Trial Reconfirms Strong Evidence Pycnogenol(R) Lowers Joint Pain, Symptoms; May Now Have Lasting Effect on Joints Following Cessation

of the Extract

HOBOKEN, N.J., Sept. 3 /PRNewswire/ -- According to the Center for Disease Control (CDC), osteoarthritis, the most common type of arthritis, is on the rise. A new study published in the August journal of Phytotherapy Research, reveals Pycnogenol(R), bark extract from the French maritime pine tree, reduced overall knee osteoarthritis (OA) symptoms by 20.9 percent and lowered pain by 40.3 percent. To date, this is the third clinical trial on osteoarthritis treatment with Pycnogenol(R). This study investigated what happens to joint symptoms after treatment with Pycnogenol is terminated and the results show that no relapse occurred after two weeks. Pycnogenol acts as potent anti-inflammatory and the lasting effects found in this study suggest that Pycnogenol may help the joints to recover.

With osteoarthritis cases on the rise, many are seeking non-traditional medication to help ease the pain and reduce the amount of traditional medication taken. The CDC estimates osteoarthritis affects 34 percent of all adults over the age of 65. In 2005, an estimated 26.9 million adults in the U.S. had osteoarthritis, which was up from 21 million in 1990. While there's no known cure for osteoarthritis, treatments such as nonsteroidal anti- inflammatory drugs (NSAIDs) or analgesics can help reduce pain and also maintain joint movement, to help the quality of life for people living with the disease. In more severe cases, cortisone shots and joint replacement surgery are used to treat OA.

"The current study is in accordance with the two previous Pycnogenol(R) studies for osteoarthritis," said Dr. Peter Rohdewald, one of the researchers of the study. "Again the pain is gradually decreasing during the course of three months treatment with Pycnogenol(R). An improvement is
'/>"/>

SOURCE Natural Health Science Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
2. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
3. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
4. Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b
5. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
6. American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast
7. Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel
8. Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study
9. National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births
10. Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
11. Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ICK, Mass. and LONDON, Nov. 20 /PRNewswire-FirstCa...) today announced that it has received 510(k) clea...FDA) and CE Mark approval to market its WallFlex&#...ent of malignant esophageal strictures (obstructio...r non-resectable esophageal cancer. ,, (Photo:...
(Date:11/20/2009)...YMOUTH MEETING, Pa., Nov. 20 /PRNewswire-USNewswir...icle that questions why currently available medica...re being ignored, ECRI Institute, an independent n...e evidence on Finasteride for Prevention of Prost...r 13, 2009, New York Times article, " Drugs to D...
(Date:11/20/2009)...NCETON, N.J., Nov. 20 So...x or the Company), formerly known as DOR BioPharma...ced today that it has formed a consortium to devel...d other rapidly acting vaccines. Soligenix receive... of Allergy and Infectious Diseases (NIAID), a div...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 1Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 2Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 3Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 4T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 1T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 2T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 3Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 1Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 2Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 3
...uly 16 MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP )...2 study evaluating the safety, tolerability and,ph... published in the July,issue of Current Medical Re...ing MAP0004, an orally inhaled and self-administer..., The study results, which were first announced l...
...ble Phase 1 RX-3341 Results -, NEW HAVEN, Conn., ...he "Company"), a development-stage company focused...tics for the treatment of,antibiotic-resistant inf...,2 clinical trial for an intravenous form of antib...ated skin and skin structure infections (cSSSIs).,...
Other Medicine Technology:MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 3
(Date:11/20/2009)..., (Seattle, Washington) November 20, 2009Emergenc...ates assess an estimated 350,000 cardiac arrests e... sudden cardiac arrest survive. Better quality ca...ospital EMS providers may be associated with bette...sortium (ROC) is the largest clinical research net...
(Date:11/20/2009)... 1 in 4 thinks it,s as short as 34 weeks, potentia..., , FRIDAY, Nov. 20 (HealthDay News) -- R...ries continues to climb in the United States. Now...are confused about what constitutes a full-term bi...new mothers surveyed in the study considered a bab...
(Date:11/20/2009)... Canadian study finds more severe cases than with ...hDay News) -- Canadian researchers are reporting t...p severe cases of H1N1 flu than seasonal flu. ,... factor for admission with pandemic H1N1 influenza...r samples," wrote Dr. Upton Allen and fellow resea...
(Date:11/20/2009)..., Longtime OB/GYN warns a...sed by the U.S. Preventative Services Task Force. ...ome at the price of human lives. When is it wrong ...The new U.S. Preventative Services Task Force reco... Annals of Internal Medicine, has set off a firest...
(Date:11/20/2009)..., , SPRINGFIELD, Mo., Nov. 20 /PRNewswire/...South Central Missouri regions will now have the o...reement reached Tuesday between Missouri Consolida...s. ,, The Southwest and South Central Missouri ...ton, Cedar, Christian, Dade, Dallas, Douglas, Gree...
Breaking Medicine News(10 mins):Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2
... medicines with the right food could improve the e...apidly rising costs of treating patients, experts ...ists Mark Ratain, MD, and Ezra Cohen, MD, have rel...d absorption of the drug. Previo...
...n example for others to follow, the Varanavasi Vil...imposed a ban on tobacco consumption among village...of tobacco consumption, the village panchayat unan...cco products like cigarette and gutka. Hence, the ...
...lly should stop complaining about their problems w...se who do so, are at a greater risk of developing ...ciate professor of psychological sciences in the C... seventh and ninth grade students - boys and girls...
...n minister in charge of womens affairs has announc...up hospices for HIV positive women . Minis...ry said, "We plan to start hospices in villages fo...iant." The hospices would be in village...
...s in the US have claimed that scorpion venom may h... Scorpions occur naturally in parts of Afri... of scorpions are harmless to human beings althoug... in scorpion venom can distinguish cancer from hea...
... origin scientist at the Rensselaer Polytechnic In...artificial muscles using carbon nanofibres . ...stimulus, thereby creating a smoother, more human-...mplantation, say scientists. Today's most pro...
Other Medicine News:Health News:Right Foods Could Improve Drug Effectiveness, Lower Drug Costs 2Health News:Village Panchayat in Tamil Nadu Bans Tobacco Consumption 2Health News:Complaining Girls Faces Higher Depression, Anxiety Risk 2Health News:India Plans Hospices for HIV Positive Women 2
ENDOLOOP Suture Type - 0 PDSII
ENDOLOOP Suture Type - 0 Coated VICRYL
HemoCue 201 DM System, Glucose
Bartels® C. Difficile Toxin A Antigen EIA with Controls
Medicine Products: